首页> 外文期刊>癌と化学療法 >A case of diffuse invasive hepatocellular carcinoma associated with thrombosis of the main trunk of the portal vein in which hepatic transcatheter arterial chemoembolization concomitant to the use of degradable starch microspheres (DSM-TACE) was very
【24h】

A case of diffuse invasive hepatocellular carcinoma associated with thrombosis of the main trunk of the portal vein in which hepatic transcatheter arterial chemoembolization concomitant to the use of degradable starch microspheres (DSM-TACE) was very

机译:一例与门静脉主干血栓形成相关的弥漫性浸润性肝细胞癌病例中,肝经导管动脉化学栓塞与可降解淀粉微球(DSM-TACE)的使用非常相关

获取原文
获取原文并翻译 | 示例
           

摘要

The case reported here was a 80-year-old male who was presented with a diffuse type of hepatocellular carcinoma accompanied by thrombosis of the main trunk of the portal vein. The primary focus and portal vein thrombosis improved considerably following repeated transcatheter arterial chemoembolization using DSM (DSM-TACE). DSM-TACE was suggested to have the potential for becoming a new treatment method for advanced hepatocellular carcinoma, for which conventional transcatheter arterial embolization (TAE) using Lipiodol and so forth is contraindicated tue to thrombosis of the main trunk of the portal vein.
机译:此处报道的病例为一名80岁男性,他患有弥漫型肝细胞癌,并伴有门静脉主干血栓形成。使用DSM(DSM-TACE)反复经导管动脉栓塞化疗后,主要病灶和门静脉血栓形成明显改善。 DSM-TACE被认为有可能成为晚期肝细胞癌的一种新治疗方法,为此,使用Lipiodol等的常规经导管动脉栓塞术(TAE)被禁止用于门静脉主干血栓形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号